GRAIL, Inc. (GRAL) Q2 2026 Earnings Call Transcript

SA Transcripts 161.55K Followers Follow GRAIL, Inc. ( GRAL ) Q2 2026 Earnings Call August 5, 2026 4:30 PM EDT Company Participants Joshua Ofman - CEO & Director Aaron Freidin - CFO & Head of Corporate Development Andrew Partridge - Chief Growth Officer Harpal Kumar - Chief Scientific Officer and President of Global Clinical & Medical Affairs Conference Call Participants Subhalaxmi Nambi - Guggenheim Securities, LLC, Research Division Kyle Mikson - Canaccord Genuity Corp., Research Division Bradley Bowers - Mizuho Securities USA LLC, Research Division Daniel Brennan - TD Cowen, Research Division Karan Patel Kallum Titchmarsh - Morgan Stanley, Research Division Presentation Operator Good day, ladies and gentlemen, and welcome to the GRAIL Second Quarter 2026 Earnings Call. [Operator Instructions] Please be advised that this conference call is being recorded. GRAIL Investor Relations, please begin. Unknown Attendee Thank you, and thank you all for joining us today. On the call are Joshua Ofman, our Chief Executive Officer; Aaron Freidin, Chief Financial Officer; -- sir Harpal Kumar, Chief Scientific Officer and President, Global Clinical and Medical Affairs; and Andrew Partridge, Chief Growth Officer. I'll remind you that we'll be making forward-looking statements based on current expectations. It's our intent that all statements other than statements of historical fact, including statements regarding our anticipated financial results and commercial activity will be covered by the safe harbor provisions for forward-looking statements under federal securities laws. Forward-looking statements are subject to risks and uncertainties. Actual events or results may differ materially from those projected or discussed. All forward-looking statements are based upon currently available information, and GRAIL assumes no obligation to update these statements. To better understand the risks and uncertainties that could cause actual results to differ, we refer you to the documents that GRAIL files with the Securities and Exchange Commission, including the Risk Factors section in GRAIL's most recent annual report on Form 10-K and